Table 1 Baseline patient characteristics
Characteristics (n = 53) | Result |
|---|---|
Male sex, n (%) | 28 (53) |
Age | |
Median, years (range) | 65.3 (38–83) |
≥ 75 years, n (%) | 9 (17.0) |
ECOG PS, n (%) | |
0 | 38 (71.7) |
1 | 14 (26.4) |
2 | 1 (1.9) |
Body weight | |
Mean ± SD, kg | 59.7 ± 8.9 |
≤ 60 kg, n (%) | 28 (52.8) |
Platelet count of 50,000–100,000/μL, n (%) | 2 (3.8) |
Pretreatment creatinine clearance, n (%) | |
≤ 50 mL/min | 2 (3.8) |
> 50–80 mL/min | 29 (54.7) |
> 80 mL/min | 22 (41.5) |
VTE diagnosis, n (%) | |
PE with or without DVT | 11 (20.8) |
Proximal DVT | 40 (75.5) |
Distal DVT | 4 (7.5) |
Location of DVT, n (%) | |
Internal jugular vein | 7 (13.2) |
Subclavian vein | 12 (22.6) |
Axillary vein | 1 (1.9) |
Superior vena cava | 13 (24.5) |
Portal vein | 1 (1.9) |
Superior mesenteric vein | 1 (1.9) |
Ovarian vein | 4 (7.5) |
Femoral vein | 1 (1.9) |
Soleal vein | 3 (5.7) |
Anterior tibial vein | 1 (1.9) |
Posterior tibial vein | 1 (1.9) |
Peroneal vein | 2 (3.8) |
Currently receiving cancer treatment, n (%) | |
Chemotherapy for advanced/metastatic cancer | 48 (90.6) |
Neo-adjuvant chemotherapy | 2 (3.8) |
Adjuvant chemotherapy | 3 (5.7) |
Primary tumor type, n (%) | |
Colorectal | 30 (56.6) |
Esophageal | 6 (11.3) |
Gastric | 6 (11.3) |
Pancreatic | 9 (17.0) |
Other | 2 (3.8) |
CVC placement, n (%) | |
No | 6 (11.3) |
Yes | 47 (88.7) |